After watching his father die from heart valve disease, a mechanical engineer used his expertise in fluid dynamics to develop a first-of-its-kind procedure to replace leaking or regurgitating heart valves without touching the heart.
Wearable technologies, possible changes to stenting practices, state legislation on energy drinks, expanded use of minimally invasive heart repair procedures, and the development of a new class of cholesterol lowering drugs are among top stories anticipated in cardiology in 2015.
DAIC readers chose the following stories as the most popular content in 2014, based on website analytics. The list is broken into the top 20 most popular news items from 2014 and a list of the top 20 archived technical articles accessed in 2014.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Now that transcatheter aortic valve replacement (TAVR) is rapidly becoming an established treatment option, cardiology has shifted focus toward the next major frontier in interventional structural heart technology — transcatheter mitral valve repair (TMVR). It was very obvious at the 2014 Transcatheter Cardiovascular Therapeutics (TCT) meeting that mitral valve technology will become the next major trend, as sessions on this topic where packed to capacity.
Zoll Medical Corp. announced that it will acquire Advanced Circulatory Systems Inc.
Medical market analyst firm GlobalData said the medical device tax has been a distraction to the overall goal of lower healthcare costs.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Image Wisely.org now offers online educational materials for fluoroscopy, computed tomography (CT) and nuclear medicine exams. Fluoroscopy is the latest addition to Image Wisely, which helps radiology providers optimize radiation dose and provide safe, effective imaging care.
Manufacturers have introduced hybrid imaging systems that combine positron emission tomography (PET) with magnetic resonance imaging (MRI). The purported benefit is improved detail in organ and soft-tissue images without the ionizing radiation inherent with systems that combine PET with computed tomography (CT), the gold-standard hybrid imaging modality.
The results of a study published online and in Circulation indicate that a medical device from Medtronic, Inc., the IN.PACT Admiral drug-coated balloon (DCB), outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg, specifically, the superficial femoral and proximal popliteal arteries.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
The American College of Cardiology and the American Heart Association released clinical data standards for cardiovascular and endpoints in clinical trials.
The results of a landmark study published this month in Circulation indicate that a device from Medtronic Inc. called the IN.PACT Admiral drug-coated balloon (DCB) significantly outperformed standard balloon angioplasty in the treatment of symptomatic peripheral artery disease in the upper leg.
The Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Fovia Medical, Inc. announced the introduction of an expanded high definition volume rendering software suite, featuring F.A.S.T. HDVR, at RSNA 2014.
Double Black Imaging released a new MRI safe display at RSNA 2014.
Tendyne Holdings Inc. announced that in November 2014, the Tendyne Transcatheter Mitral Valve Implantation system (TMVI) was successfully implanted in the first patient of the Tendyne Feasibility Study. This was the first patient enrolled in a three continent, multicenter trial, which aims to generate insight into the safety and performance of the Tendyne device in inoperable patients suffering from mitral regurgitation.